User profiles for Max R. O’Donnell

Max O'Donnell

Columbia University Medical Center
Verified email at columbia.edu
Cited by 7602

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

…, J Salazar-Schicchi, NH Yip, D Brodie, MR O'Donnell - The lancet, 2020 - thelancet.com
… bodyweight, median plateau airway pressure 27 cm H 2 O), as were levels of positive end-expiratory
pressure (PEEP; median maximum PEEP 15 cm H 2 O within the first 24 h). 25% of …

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

…, I Monedero, P Nahid, N Ndjeka, MR O'Donnell… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …

A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19

MR O'Donnell, B Grinsztejn… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Although convalescent plasma has been widely used to treat severe
coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its …

Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study

…, DD Markowitz, A Gupta, MR O'Donnell… - …, 2020 - gastrojournal.org
Methods Complete methods are available in the Supplementary Materials. In brief, adults
were eligible for the study if they were admitted to our institution from February 25, 2020, to …

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates …

…, J Wortman, KP Mlisana, MR O'Donnell… - PLoS …, 2015 - journals.plos.org
Background The continued advance of antibiotic resistance threatens the treatment and
control of many infectious diseases. This is exemplified by the largest global outbreak of …

Latent class analysis reveals COVID-19–related acute respiratory distress syndrome subgroups with differential responses to corticosteroids

…, CS Calfee, D Brodie, MR O'Donnell - American journal of …, 2021 - atsjournals.org
Rationale: Two distinct subphenotypes have been identified in acute respiratory distress
syndrome (ARDS), but the presence of subgroups in ARDS associated with coronavirus …

High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers

MR O'Donnell, J Jarand, M Loveday… - Annals of internal …, 2010 - acpjournals.org
Background: Nosocomial transmission has been described in extensively drug-resistant
tuberculosis (XDR-TB) and HIV co-infected patients in South Africa. However, little is known …

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance

…, AL Manson, A Salazar, N Padayatchi, MR O'Donnell… - Nature …, 2016 - nature.com
A more complete understanding of the genetic basis of drug resistance in Mycobacterium
tuberculosis is critical for prompt diagnosis and optimal treatment, particularly for toxic second-…

… antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials

AJ Walkey, MR O'Donnell, RS Wiener - Chest, 2011 - Elsevier
Background Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of
nosocomial pneumonia. Societal guidelines suggest linezolid may be the preferred treatment …

[HTML][HTML] Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection

MR O'Donnell, N Padayatchi… - Emerging infectious …, 2013 - ncbi.nlm.nih.gov
High mortality rates have been reported for patients co-infected with extensively drug-resistant
tuberculosis (XDR-TB) and HIV, but treatment outcomes have not been reported. We …